Introduction/Overview
Aristololactam (CAS number: 13395-02-3), as one of the main metabolites of Aristolochic acid (AA), has attracted widespread attention in the field of natural product pharmacology in recent years due to its significant cytotoxicity and potential kidney damage. Aristolochic acid and its related compounds are widely present in Aristolochiaceae plants and have traditionally been used in traditional Chinese medicine and folk therapy. However, with further research on its toxicological properties, Aristolochia lactiflora has been confirmed to play an important role in the pathogenesis of kidney injury, urothelial carcinoma, and other related diseases. Of particular note is that the cytotoxic efficacy of aristolochic amide is significantly higher than that of its parent compound aristolochic acid, providing a new perspective for its potential pharmacological activity and toxicity mechanism research.
This article will provide a systematic review of the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activities, and mechanisms of action of Aristolochia lactiflora, with a particular focus on its molecular mechanism of inducing cell apoptosis through the caspase 3-dependent pathway. In addition, by combining its pharmacological parameters and pharmacokinetic characteristics, the potential and risks of its clinical application are evaluated, aiming to provide comprehensive and in-depth reference materials for natural product pharmacology researchers and scientists in related fields.
Chemical structure and physicochemical properties
Aristolochiaceae is an important member of aristolochic acid metabolites, with a molecular formula of C18H15NO3 and a molecular weight of 293.27. Its structural features mainly include a lactam ring system connected to the aristolochic acid skeleton, forming stable aromatic lactam derivatives. This structure endows it with certain hydrophobicity and biological activity.
In terms of physicochemical properties, the LogP value of Aristolochia lactiflora is 2.2, indicating its moderate lipid solubility, which is beneficial for membrane penetration and bioavailability. Its topological polar surface area (TPSA) is 78.96 Å ², indicating moderate polarity and a certain degree of hydrophilicity and hydrophobicity, making it suitable for interacting with various biomolecules. This molecule contains 5 hydrogen bond acceptors, which may be involved in various hydrogen bond mediated molecular recognition processes.
The low permeability of the blood-brain barrier suggests limited accumulation in the central nervous system, which may reduce the risk of central neurotoxicity. Positive liver toxicity suggests that it may produce toxic metabolites or induce liver cell damage during liver metabolism. It is worth noting that Aristolochia lactiflora did not exhibit cardiotoxicity or hERG channel inhibition, but showed a positive Ames test, indicating a potential genotoxicity risk.
Plant sources and extraction methods
Aristolochiaceae mainly exists in plants of the Aristolochiaceae family, especially in the rhizomes and leaves of Aristolochia spp. and Asarum spp. In traditional Chinese medicine, these plants are widely used for treatments such as promoting blood circulation, removing blood stasis, reducing swelling, and relieving pain. However, the toxicity of aristolochic acids and their metabolites contained in them is gradually being revealed.
The common methods for extracting Aristolochia lactiflora include organic solvent extraction and chromatographic separation techniques. Generally, methanol or ethanol is used as the extraction solvent to obtain crude extracts through ultrasound assisted extraction or reflux extraction. Subsequently, purification and separation were carried out using techniques such as silica gel column chromatography and high-performance liquid chromatography (HPLC). In recent years, supercritical fluid extraction and solid-phase extraction techniques have also been applied to improve extraction efficiency and purity.
Given the structural stability of aristolochic acid and its metabolic relationship with aristolochic acid, some studies have used in vitro enzymatic metabolism simulation systems to indirectly obtain aristolochic acid through liver microsomal or cell models, facilitating its biological activity and toxicological research.
Pharmacological activity research
The pharmacological activity research of Aristolochia lactiflora mainly focuses on its cytotoxicity and ability to induce cell apoptosis. Multiple in vitro cell experiments have shown that aristolochic acid has significant cytotoxic effects on renal tubular epithelial cells, urinary tract epithelial cells, and various tumor cells, with a cytotoxicity intensity greater than that of the parent compound aristolochic acid.
Studies on the mechanism of cytotoxicity have shown that aristolochic amide induces programmed cell death by activating the caspase-3 dependent apoptotic pathway. This process is accompanied by the loss of mitochondrial membrane potential, release of cytochrome c, and regulation of apoptosis related protein expression. In addition, aristolochic amide can also trigger oxidative stress response, increase reactive oxygen species (ROS) generation, and further promote cell damage.
In animal models, the nephrotoxicity of aristolochic amide is manifested as necrosis and fibrosis of renal tubular epithelial cells, leading to renal dysfunction. Its toxic effects are closely related to aristolochic acid nephropathy (AAN) associated with aristolochic acid, indicating that this metabolite plays a critical role in the occurrence and development of the disease.
In addition, there is a potential interaction between Aristolochia lactiflora and molecular targets associated with myocardial infarction. Although there is currently no direct evidence to suggest its therapeutic effect on myocardial infarction, its binding to targets such as APP, PTPN1, MAOA, ABCB1, ABCG2, SYNJ2, ALOX5, TRPV1, CNR1, and SHBG may affect cardiovascular function and pathological processes, which deserves further exploration.
Mechanism of action and molecular targets
The cytotoxicity of Aristolochia lactiflora is mainly mediated through the caspase-3-dependent apoptotic pathway. The specific mechanism includes:
-
Cascade activation of cysteine protease
Aristolochia lactiflora induces activation of the mitochondrial pathway, leading to the release of cytochrome c into the cytoplasm, which in turn activates caspases 9 and 3, executing the apoptotic program. As a key executing enzyme, caspase 3 cleaves multiple substrates, leading to nuclear DNA breakage and membrane structure disruption.
-
Oxidative stress and ROS generation
This compound promotes an increase in intracellular ROS levels, oxidative stress damages cell membrane lipids, proteins, and DNA, and activates the apoptotic signaling pathway. The application of antioxidants can partially alleviate their cytotoxicity and support the importance of oxidative stress in their mechanism of action.
-
Formation of DNA adducts and genotoxicity
Aristolochia lactiflora can form adducts with DNA, causing DNA damage and mutations. A positive Ames test result suggests its genotoxic potential. This DNA damage may trigger cell cycle arrest and apoptosis.
-
Molecular target association
Through molecular docking and bioinformatics analysis, Aristolochia lactiflora may bind to various targets associated with myocardial infarction, including APP (amyloid precursor protein), PTPN1 (protein tyrosine phosphatase 1), MAOA (monoamine oxidase A), ABC transporters (ABCB1, ABCG2), SYNJ2 (phosphatidylinositol phosphatase), ALOX5 (lipoxygenase 5), TRPV1 (transient receptor potential vanillic acid subfamily member 1), CNR1 (cannabinoid receptor 1), and SHBG (sex hormone binding globulin). These targets involve inflammation response, ion channel regulation, neurotransmitter metabolism, and hormone regulation, suggesting that Aristolochia lactiflora may affect cardiovascular and other system functions through multiple targets and pathways.
Evaluation of drug properties and pharmacokinetics
From the perspective of medicinal properties, Aristolochia lactiflora has the following characteristics:
-
Molecular weight and lipid solubility
The molecular weight of 293.27 conforms to Lipinski's rule, with a LogP of 2.2, indicating moderate lipid solubility, which is beneficial for the drug's biofilm penetration and oral absorption.
-
Polarity and Hydrogen Bond Receptors
The TPSA is 78.96 Å ² and the number of hydrogen bond acceptors is 5, indicating that its polarity is moderate and may have good solubility and distribution characteristics in vivo.
-
Blood-brain barrier permeability
Low prediction reduces the risk of central nervous system toxicity, but limits its potential application in central nervous system diseases.
-
Toxicity risk
Positive hepatotoxicity suggests caution about liver safety issues, while a positive Ames test indicates potential mutagenicity, limiting its direct use as a drug.
-
Cardiac safety
No cardiac toxicity and hERG channel inhibition, reducing the risk of arrhythmia, which is beneficial for safety evaluation.
In terms of pharmacokinetics, although there is limited specific in vivo metabolic data, as a metabolite of aristolochic acid, aristolochic acid lactam may be further converted through the liver metabolic enzyme system. Its low blood-brain barrier permeability and liver toxicity suggest the need for close monitoring of liver function and potential metabolite toxicity during distribution and metabolism in the body.
Clinical application prospects and prospects
Despite exhibiting strong cytotoxicity and potential pathogenic risks, the direct clinical application of Aristolochia lactiflora is severely limited. However, from the perspectives of pharmacology and toxicology research, aristolochic acid lactams provide important models for studying disease mechanisms, particularly in aristolochic acid nephropathy and related renal fibrosis diseases.
Future research can focus on:
-
In depth analysis of toxicity mechanisms
Through multi omics techniques and high-throughput screening, the interaction between aristolochic acid lactam and key proteins and signaling pathways in cells is further clarified, providing targets for the prevention and treatment of aristolochic acid related diseases.
-
Structural modification and toxicity reduction
Reducing its hepatotoxicity and genotoxicity through chemical modification and exploring safer derivatives may provide new ideas for the development of natural product drugs.
-
Research on multi-target pharmacological effects
Using molecular docking and cellular functional validation, explore its regulatory potential on myocardial infarction related targets and evaluate its potential role in cardiovascular disease.
-
Development of biomarkers
Develop relevant biomarkers based on the metabolic characteristics of aristolochic acid lactam for early diagnosis of aristolochic acid nephropathy and related toxicity monitoring.
In summary, although Aristolochia lactiflora has a high toxicity risk, its value in disease mechanism research and drug development cannot be ignored. Reasonably utilizing its pharmacological properties, combined with modern drug design and safety evaluation, is expected to promote the scientific application of related natural products.
Conclusion
Aristolochia lactiflora, as the main metabolite of aristolochic acid, has important research value in the field of natural product pharmacology due to its significant cytotoxicity and complex mechanism of action. It induces cell death through a caspase-3-dependent apoptotic pathway and is involved in the occurrence and development of kidney injury and related diseases. Although its hepatotoxicity and genotoxicity limit its direct clinical application, in-depth analysis of its molecular mechanism of action can help reveal the essence of aristolochic acid toxicity and provide a theoretical basis for the prevention and treatment of related diseases.
In the future, combining modern medicinal chemistry, molecular biology, and toxicology techniques to optimize the structure and improve the safety of Aristolochia lactiflora will open up new paths for the development of natural product drugs. Meanwhile, based on its multi-target action characteristics, aristolochic amide may also become an important tool for studying the molecular mechanisms of cardiovascular and kidney diseases, promoting scientific progress in related fields.
